Citi analyst Joanne Wuensch reiterated a Neutral rating and $94.00 price target on Haemonetics (NYSE: HAE) and opened a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE